1. Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles
   Gabriella Schiera et al, 2017, International Journal of Molecular Sciences CrossRef
2. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art
   Guangying Lu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence
   Martina Čižmáriková et al, 2023, Biomolecules CrossRef
4. Synergistic Therapies for Recurrent Malignant Gliomas
   Joshua E. Simon et al, 2020, World Neurosurgery CrossRef
5. A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide
   Steliana Tsouri et al, 2024, Pharmaceuticals CrossRef
6. Therapeutic efficacy of gut microbiota-derived polyphenol metabolite Urolithin A
   Shilpa S. Shetty et al, 2024, Beni-Suef University Journal of Basic and Applied Sciences CrossRef
7. miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma
   Dehua Li et al, 2017, Oncotarget CrossRef
8. Study on the stability control strategy of Triphala solution based on the balance of physical stability and chemical stabilities
   Hao-zhou Huang et al, 2018, Journal of Pharmaceutical and Biomedical Analysis CrossRef
9. Anti-inflammatory effect and antihepatoma mechanism of carrimycin
   Xiu-Yan Li et al, 2023, World Journal of Gastroenterology CrossRef
10. Regulation of the Notch signaling pathway by natural products for cancer therapy
    Jiayi Cai et al, 2024, The Journal of Nutritional Biochemistry CrossRef
11. Ellagic acid as a potent anticancer drug: A comprehensive review on in vitro, in vivo, in silico, and drug delivery studies
    Arash Mohammadinejad et al, 2022, Biotechnology and Applied Biochemistry CrossRef
12. Ellagic Acid Enhances the Antitumor Efficacy of Bevacizumab in an In Vitro Glioblastoma Model
    Abdurrahman Çetin et al, 2019, World Neurosurgery CrossRef
13. The Potential as New Treatment Agent of Urolithin-A Metabolized from Ellagic Acid by Gut Microbiota in Cancer
    TOSHIYUKI OKUMURA, 2021, Juntendo Medical Journal CrossRef
14. Tannins in cancer prevention and therapy
    Robert Kleszcz et al, 2023, British Journal of Pharmacology CrossRef
15. Synergism of ellagic acid in combination with radiotherapy and chemotherapy for cancer treatment
    Peiyu Xue et al, 2022, Phytomedicine CrossRef
16. Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
    Claudia Ceci et al, 2018, Nutrients CrossRef
17. Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid
    Guendalina Zuccari et al, 2020, Applied Sciences CrossRef
18. Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model
    Abdurrahman Çetin et al, 2019, World Neurosurgery CrossRef
19. Ligand fishing as a tool to screen natural products with anticancer potential
    Luiz Antonio Miranda de Souza Duarte‐Filho et al, 2023, Journal of Separation Science CrossRef
20. Potential use of ellagic acid for endometriosis treatment: its effect on a human endometrial cell cycle, adhesion and migration
    B. A. Mc Cormack et al, 2020, Food & Function CrossRef
21. Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
    Ying-Si Wu et al, 2021, Cancers CrossRef
22. Potential of Polyphenolic Nutraceuticals in the Management of Glioblastoma Multiforme
    Swati Devendra Raysing et al, 2022, Current Nutraceuticals CrossRef